Multifunctional metal complex-based gene delivery for tumour immune checkpoint blockade combination therapy

References

• Zhang X, Wang C, Wang J, et al. PD-1 blockade cellular vesicles for cancer immunotherapy. Adv Mater. 2018;30(22):1707112.
   PubMed Web of Science ®Google Scholar
• Makaremi S, Asadzadeh Z, Hemmat N, et al. Immune checkpoint inhibitors in colorectal cancer: challenges and future prospects. Biomedicines. 2021;9(9):1075.
   PubMed Web of Science ®Google Scholar
• Relecom A, Merhi M, Inchakalody V, et al. Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity. J Exp Clin Cancer Res. 2021;40(1):74.
   PubMed Web of Science ®Google Scholar
• Wang X, Guo G, Guan H, et al. Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma. J Exp Clin Cancer Res. 2019;38(1):87.
   PubMed Web of Science ®Google Scholar
• Zhang M, Liu KH, Wang MF. Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade. RSC Adv. 2019;9(58):33903–33911.
   PubMed Web of Science ®Google Scholar
• Lemaire V, Shemesh CS, Rotte A. Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations. J Exp Clin Cancer Res. 2021;40(1):311.
   PubMed Web of Science ®Google Scholar
• Maleki VS, Garrigos C, Duran I. Biomarkers of response to PD-1/PD-L1 inhibition. Crit Rev Oncol Hematol. 2017;116:116–124.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P. The interaction of anticancer therapies with tumor-associated macrophages. J Exp Med. 2015;212(4):435–445.
   PubMed Web of Science ®Google Scholar
• Chen Y, Mengru H, Lei W, et al. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020;877:173090.
   PubMed Web of Science ®Google Scholar
• He X, Liu B, Wu J, et al. A dual macrophage targeting nanovector for delivery of oligodeoxynucleotides to overcome cancer-associated immunosuppression. ACS Appl Mater Interfaces. 2017;9(49):42566–42576.
   PubMed Web of Science ®Google Scholar
• Li CX, Zhang Y, Dong X, et al. Artificially reprogrammed macrophages as tumor-tropic immunosuppression-resistant biologics to realize therapeutics production and immune activation. Adv Mater. 2019;31(15):e1807211.
   PubMed Web of Science ®Google Scholar
• Sindrilaru A, Peters T, Wieschalka S, et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 2011;121(3):985–997.
   PubMed Web of Science ®Google Scholar
• Zanganeh S, Hutter G, Spitler R, et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol. 2016;11(11):986–994.
   PubMed Web of Science ®Google Scholar
• Juang RS, Chen MN. Measurement of binding constants of poly(ethylenimine) with metal ions and metal chelates in aqueous media by ultrafiltration. Ind Eng Chem Res. 1996;35(6):1935–1943.
   Web of Science ®Google Scholar
• Dautry-Varsat A, Ciechanover A, Lodish H. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA. 1983;80(8):2258–2262.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Angeli JPF, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285.
   PubMed Web of Science ®Google Scholar
• Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165–176.
   PubMed Web of Science ®Google Scholar
• Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1-2):317–331.
   PubMed Web of Science ®Google Scholar
• Rouault TA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol. 2006;2(8):406–414.
   PubMed Web of Science ®Google Scholar
• Corot C, Robert P, Idee JM, et al. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006;58(14):1471–1504.
   PubMed Web of Science ®Google Scholar
• Tang ZM, Liu YY, He MY, et al. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions. Angew Chem Int Ed Engl. 2019;58(4):946–956.
   PubMed Web of Science ®Google Scholar
• Wang XG, Dong ZY, Cheng H, et al. A multifunctional metal-organic framework based tumor targeting drug delivery system for cancer therapy. Nanoscale. 2015;7(38):16061–16070.
   PubMed Web of Science ®Google Scholar
• Burk J, Sikk L, Burk P, et al. Fe-doped ZnO nanoparticle toxicity: assessment by a new generation of nanodescriptors. Nanoscale. 2018;10(46):21985–21993.
   PubMed Web of Science ®Google Scholar
• Huang G, Liu R, Hu Y, et al. FeOOH-loaded mesoporous silica nanoparticles as a theranostic platform with pH-responsive MRI contrast enhancement and drug release. Sci China Chem. 2018;61(7):806–811.
   Web of Science ®Google Scholar
• Chen J, Lei S, Zeng K, et al. Catalaseimprinted Fe3O4/Fe@fibrous SiO2/polydopamine nanoparticles: an integrated nanoplatform of magnetic targeting, magnetic resonance imaging, and dual-mode cancer therapy. Nano Res. 2017;10(7):2351–2363.
   Web of Science ®Google Scholar
• Huang G, Chen H, Dong Y, et al. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics. 2013;3(2):116–126.
   PubMed Web of Science ®Google Scholar
• Zhang C, Bu W, Ni D, et al. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction. Angew Chem Int Ed Engl. 2016;55(6):2101–2106.
   PubMed Web of Science ®Google Scholar
• Ma P, Xiao H, Yu C, et al. Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species. Nano Lett. 2017;17(2):928–937.
   PubMed Web of Science ®Google Scholar
• Wu H, Cheng K, He Y, et al. Fe3O4-based multifunctional nanospheres for amplified magnetic targeting photothermal therapy and fenton reaction. ACS Biomater Sci Eng. 2019;5(2):1045–1056.
   PubMed Web of Science ®Google Scholar
• Von Mässenhausen A, Tonnus W, Linkermann A. Cell death pathways drive necroinflammation during acute kidney injury. Nephron. 2018;140(2):144–147.
   PubMed Web of Science ®Google Scholar
• Martin-Sanchez D, Ruiz-Andres O, Poveda J, et al. Ferroptosis, but not necroptosis, is important in nephrotoxic folic Acid-Induced AKI. J Am Soc Nephrol. 2017;28(1):218–229.
   PubMed Web of Science ®Google Scholar
• Song W, Shen L, Wang Y, et al. Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nat Commun. 2018;9(1):2237.
   PubMed Web of Science ®Google Scholar
• Miao L, Li J, Liu Q, et al. Transient and local expression of chemokine and immune checkpoint traps to treat pancreatic cancer. ACS Nano. 2017;11(9):8690–8706.
   PubMed Web of Science ®Google Scholar
• Li L, Song L, Yang X, et al. Multifunctional “core-shell” nanoparticles-based gene delivery for treatment of aggressive melanoma. Biomaterials. 2016;111:124–137.
   PubMed Web of Science ®Google Scholar
• Yagoda N, von Rechenberg M, Zaganjor E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447(7146):864–868.
   PubMed Web of Science ®Google Scholar
• Cheng ZY, Li YZ. What is responsible for the initiating chemistry of iron-mediated lipid peroxidation: an update. Chem Rev. 2007;107(3):748–766.
   PubMed Web of Science ®Google Scholar
• Seiler A, Schneider M, Förster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8(3):237–248.
   PubMed Web of Science ®Google Scholar
• Huang Y, Dong Y, Zhao J, et al. Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines. Ann Transl Med. 2019;7(20):542–542.
   PubMed Web of Science ®Google Scholar
• Rossi A, Pakhomova ON, Mollica PA, et al. Nanosecond pulsed electric fields induce endoplasmic reticulum stress accompanied by immunogenic cell death in murine models of lymphoma and colorectal cancer. Cancers. 2019;11(12):2034.
   Web of Science ®Google Scholar
• Yang Q, Shi G, Chen X, et al. Nanomicelle protects the immune activation effects of paclitaxel and sensitizes tumors to anti-PD-1 immunotherapy. Theranostics. 2020;10(18):8382–8399.
   PubMed Web of Science ®Google Scholar
• Cantor H, Shen FW, Boyse EA. Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med. 1976;143(6):1391–1340.
   PubMed Web of Science ®Google Scholar
• Ravi KD, Brian JS, Antonio La C, et al. CD8+ tregs in lupus, autoimmunity, and beyond. Autoimmun Rev. 2010;9:560–568.
   PubMed Web of Science ®Google Scholar
• Yang ZQ, Yang ZY, Zhang LD, et al. Increased liver-infiltrating CD8+ FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. Hum Immunol. 2010;71:1180–1186.
   PubMed Web of Science ®Google Scholar
• Eva B, Robert T. CD8+ regulatory T cells in persistent human viral infections. Hum Immunol. 2008;69:771–775.
   PubMed Web of Science ®Google Scholar
• Oh DY, Kwek SS, Raju SS, et al. Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell. 2020;181(7):1612–1625.
   PubMed Web of Science ®Google Scholar
• Binnewies M, Mujal A, Pollack J, et al. Unleashing type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity. Cell. 2019;177(3):556–571.e16.
   PubMed Web of Science ®Google Scholar
• Lim C, Singh A, Heo J, et al. Gadolinium-coordinated elastic nanogels for in vivo tumor targeting and imaging. Biomaterials. 2013;34(28):6846–6852.
   PubMed Web of Science ®Google Scholar
• Yao Y, Liu KH, Zhao YL, et al. Pterostilbene and 4-methoxyresveratrol inhibited lipopolysaccharide-induced inflammatory response in RAW264.7 macrophages. Molecules. 23(5):1148.
   Web of Science ®Google Scholar